Menu
Back to User profile » Dr Mike Briley
Papers published by Dr Mike Briley:
Rapid improvement of depressive symptoms in suicide attempters following treatment with milnacipran and tricyclic antidepressants – a case series
Kirino E, Gitoh M
Neuropsychiatric Disease and Treatment 2011, 7:723-728
Published Date: 14 December 2011
Choking risk among psychiatric inpatients
Nagamine T
Neuropsychiatric Disease and Treatment 2011, 7:381-382
Published Date: 20 June 2011
The noradrenergic symptom cluster: clinical expression and neuropharmacology
Blier P, Briley M
Neuropsychiatric Disease and Treatment 2011, 7:15-20
Published Date: 3 June 2011
The importance of norepinephrine in depression
Moret C, Briley M
Neuropsychiatric Disease and Treatment 2011, 7:9-13
Published Date: 31 May 2011
The increasing burden of depression
Lépine J-P, Briley M
Neuropsychiatric Disease and Treatment 2011, 7:3-7
Published Date: 31 May 2011
Improvement of the noradrenergic symptom cluster following treatment with milnacipran
Kasper S, Meshkat D, Kutzelnigg A
Neuropsychiatric Disease and Treatment 2011, 7:21-27
Published Date: 31 May 2011
Noradrenergic symptom cluster in depression
Montgomery S, Briley M
Neuropsychiatric Disease and Treatment 2011, 7:1-2
Published Date: 31 May 2011
Psychiatric diagnoses in patients with burning mouth syndrome and atypical odontalgia referred from psychiatric to dental facilities
Miho Takenoshita, Tomoko Sato, Yuichi Kato, et al
Neuropsychiatric Disease and Treatment 2010, 6:699-705
Published Date: 13 October 2010
Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
Mike Briley, Chantal Moret
Neuropsychiatric Disease and Treatment 2010, 6:647-655
Published Date: 23 September 2010
Milnacipran: a unique antidepressant?
Siegfried Kasper, Gerald Pail
Neuropsychiatric Disease and Treatment 2010, 6:23-31
Published Date: 25 August 2010
Antidepressant therapy with milnacipran and venlafaxine
Lucilla Mansuy
Neuropsychiatric Disease and Treatment 2010, 6:17-22
Published Date: 25 August 2010
Treatment of patients with comorbid depression and diabetes with metformin and milnacipran
Peter Hofmann
Neuropsychiatric Disease and Treatment 2010, 6:9-15
Published Date: 25 August 2010
Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran
Philippe Courtet
Neuropsychiatric Disease and Treatment 2010, 6:3-8
Published Date: 24 August 2010
Editorial Foreword - Milnacipran: recent findings in depression
Stuart Montgomery, Mike Briley
Neuropsychiatric Disease and Treatment 2010, 6:1-2
Published Date: 24 August 2010
Milnacipran: recent findings in depression
Guest editors: Stuart Montgomery (London, UK) and Mike Briley (Castres, France)
Neuropsychiatric Disease and Treatment 2010, 6:0-0
Published Date: 24 August 2010
Abnormal laboratory values during the acute and recovery phases in schizophrenic patients: a retrospective study
Takahiko Nagamine
Neuropsychiatric Disease and Treatment 2010, 6:281-288
Published Date: 9 June 2010
Milnacipran and venlafaxine at flexible doses (up to 200 mg/day) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomized, double-blind exploratory study
Jean-Pierre Olié, David Gourion, Agnès Montagne, et al
Neuropsychiatric Disease and Treatment 2010, 6:71-79
Published Date: 23 March 2010